Literature DB >> 17204608

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Miguel N Rivera1, Woo Jae Kim, Julie Wells, David R Driscoll, Brian W Brannigan, Moonjoo Han, James C Kim, Andrew P Feinberg, William L Gerald, Sara O Vargas, Lynda Chin, A John Iafrate, Daphne W Bell, Daniel A Haber.   

Abstract

Wilms tumor is a pediatric kidney cancer associated with inactivation of the WT1 tumor-suppressor gene in 5 to 10% of cases. Using a high-resolution screen for DNA copy-number alterations in Wilms tumor, we identified somatic deletions targeting a previously uncharacterized gene on the X chromosome. This gene, which we call WTX, is inactivated in approximately one-third of Wilms tumors (15 of 51 tumors). Tumors with mutations in WTX lack WT1 mutations, and both genes share a restricted temporal and spatial expression pattern in normal renal precursors. In contrast to biallelic inactivation of autosomal tumor-suppressor genes, WTX is inactivated by a monoallelic "single-hit" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204608     DOI: 10.1126/science.1137509

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

1.  Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Authors:  Masayuki Haruta; Yasuhito Arai; Naoki Watanabe; Yuiko Fujiwara; Shohei Honda; Junjiro Ohshima; Fumio Kasai; Hisaya Nakadate; Hiroshi Horie; Hajime Okita; Jun-Ichi Hata; Masahiro Fukuzawa; Yasuhiko Kaneko
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

2.  WTX: an unexpected regulator for p53.

Authors:  Chao Dai; Wei Gu
Journal:  Mol Cell       Date:  2012-03-09       Impact factor: 17.970

Review 3.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 4.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

5.  X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity.

Authors:  Yang Liu; Lizhong Wang; Pan Zheng
Journal:  Trends Genet       Date:  2010-04-29       Impact factor: 11.639

Review 6.  WT1 and kidney progenitor cells.

Authors:  Jordan A Kreidberg
Journal:  Organogenesis       Date:  2010 Apr-Jun       Impact factor: 2.500

7.  CITED1 expression in Wilms' tumor and embryonic kidney.

Authors:  Harold N Lovvorn; Jenifer Westrup; Shaun Opperman; Scott Boyle; Genbin Shi; James Anderson; Elizabeth J Perlman; Alan O Perantoni; Marcia Wills; Mark de Caestecker
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.

Authors:  Zandra A Jenkins; Margriet van Kogelenberg; Tim Morgan; Aaron Jeffs; Ryuji Fukuzawa; Esther Pearl; Christina Thaller; Anne V Hing; Mary E Porteous; Sixto Garcia-Miñaur; Axel Bohring; Didier Lacombe; Fiona Stewart; Torunn Fiskerstrand; Laurence Bindoff; Siren Berland; Lesley C Adès; Michel Tchan; Albert David; Louise C Wilson; Raoul C M Hennekam; Dian Donnai; Sahar Mansour; Valérie Cormier-Daire; Stephen P Robertson
Journal:  Nat Genet       Date:  2008-12-14       Impact factor: 38.330

Review 9.  Pediatric genitourinary tumors.

Authors:  Sharon M Castellino; Anibal R Martinez-Borges; Thomas W McLean
Journal:  Curr Opin Oncol       Date:  2009-05       Impact factor: 3.645

10.  Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

Authors:  Reyhan El-Kares; Pierre-Alain Hueber; Miriam Blumenkrantz; Diana Iglesias; Kim Ma; Nada Jabado; Daniel G Bichet; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.